In the past week, HSDT stock has gone down by -40.83%, with a monthly decline of -60.52% and a quarterly plunge of -65.67%. The volatility ratio for the week is 32.32%, and the volatility levels for the last 30 days are 12.98% for Helius Medical Technologies Inc The simple moving average for the past 20 days is -50.47% for HSDT’s stock, with a -66.07% simple moving average for the past 200 days.
Is It Worth Investing in Helius Medical Technologies Inc (NASDAQ: HSDT) Right Now?
The 36-month beta value for HSDT is at 1.72. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for HSDT is 0.85M, and currently, shorts hold a 8.48% of that float. The average trading volume for HSDT on May 07, 2024 was 604.94K shares.
HSDT) stock’s latest price update
Helius Medical Technologies Inc (NASDAQ: HSDT)’s stock price has dropped by -15.68 in relation to previous closing price of 2.87. Nevertheless, the company has seen a loss of -40.83% in its stock price over the last five trading days. InvestorPlace reported 2024-05-03 that Helius Medical Technology (NASDAQ: HSDT ) stock is rocketing higher on Friday alongside heavy trading of the neurotechnology company’s shares. This has more than 3.5 million shares of HSDT stock changing hands as of this writing.
Analysts’ Opinion of HSDT
Many brokerage firms have already submitted their reports for HSDT stocks, with Noble Capital Markets repeating the rating for HSDT by listing it as a “Outperform.” The predicted price for HSDT in the upcoming period, according to Noble Capital Markets is $20 based on the research report published on March 24, 2021 of the previous year 2021.
HSDT Trading at -54.83% from the 50-Day Moving Average
After a stumble in the market that brought HSDT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -83.24% of loss for the given period.
Volatility was left at 12.98%, however, over the last 30 days, the volatility rate increased by 32.32%, as shares sank -60.39% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -57.84% lower at present.
During the last 5 trading sessions, HSDT fell by -40.83%, which changed the moving average for the period of 200-days by -74.54% in comparison to the 20-day moving average, which settled at $4.70. In addition, Helius Medical Technologies Inc saw -69.90% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HSDT starting from ANDREEFF DANE, who purchase 5,000 shares at the price of $8.10 back on Dec 14 ’23. After this action, ANDREEFF DANE now owns 16,512 shares of Helius Medical Technologies Inc, valued at $40,475 using the latest closing price.
ANDREEFF DANE, the President and CEO of Helius Medical Technologies Inc, purchase 2,006 shares at $6.45 during a trade that took place back on Dec 01 ’23, which means that ANDREEFF DANE is holding 13,685 shares at $12,935 based on the most recent closing price.
Stock Fundamentals for HSDT
Current profitability levels for the company are sitting at:
- -19.3 for the present operating margin
- 0.08 for the gross margin
The net margin for Helius Medical Technologies Inc stands at -11.54. The total capital return value is set at -2.14. Equity return is now at value -168.56, with -70.86 for asset returns.
Based on Helius Medical Technologies Inc (HSDT), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -182.74. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is -65.76.
Currently, EBITDA for the company is -12.11 million with net debt to EBITDA at 0.36. When we switch over and look at the enterprise to sales, we see a ratio of -4.62. The receivables turnover for the company is 1.01for trailing twelve months and the total asset turnover is 0.08. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.88.
Conclusion
In conclusion, Helius Medical Technologies Inc (HSDT) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
